Skip to content

Cannabis: all studies

Page 117 of 288: studies 1,161 to 1,170 of 2,878, newest first. Back to the cannabis overview

Research

Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.

Journal of Pharmacology and Experimental Therapeutics January 29, 2016 Brian D Kangas, Michael Z. Leonard, Vidyanand G Shukla et al.

The primary psychoactive ingredient of marijuana, Δ(9)-tetrahydrocannabinol (Δ(9)-THC), has medicinal value but also produces unwanted deleterious effects on cognitive function, promoting the search for improved cannabinergic therapeutics. The present studies used a battery of touchscreen procedures in squirrel monkeys to compare the effects of different types of cannabinergic drugs on several...

A Case of Butane Hash Oil (Marijuana Wax)–Induced Psychosis

Substance Abuse January 28, 2016 Corey J. Keller, Evan C. Chen, Kimberly L. Brodsky et al. 27 citations

BACKGROUND: Marijuana is one of the most widely used controlled substances in the United States. Despite extensive research on smoked marijuana, little is known regarding the potential psychotropic effects of marijuana "wax," a high-potency form of marijuana that is gaining in popularity. CASE: The authors present a case of "Mr. B," a 34-year-old veteran who presented with profound psychosis in...

Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication

Addiction Biology January 14, 2016 Elizabeth B. de Sousa Fernandes Perna, Eef Lien Theunissen, Kim P. C. Kuypers et al. 24 citations

Drugs of abuse stimulate striatal dopamine release and activate reward pathways. This study examined the impact of alcohol and cannabis marketing on the reward circuit in alcohol and cannabis users while sober and intoxicated. It was predicted that alcohol and cannabis marketing would increase striatal activation when sober and that reward sensitivity would be less during alcohol and cannabis...

Hippocampal harms, protection and recovery following regular cannabis use.

Translational Psychiatry January 12, 2016 Murat Yücel, Valentina Lorenzetti, Chao Suo et al.

Shifting policies towards legalisation of cannabis for therapeutic and recreational use raise significant ethical issues for health-care providers seeking evidence-based recommendations. We investigated whether heavy cannabis use is associated with persistent harms to the hippocampus, if exposure to cannabidiol offers protection, and whether recovery occurs with abstinence. To do this, we...

Disruption of hippocampal synaptic transmission and long‐term potentiation by psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ9‐tetrahydrocannabinol

Addiction Biology January 5, 2016 Alexander F. Hoffman, Matthew D. Lycas, Jakub Kaczmarzyk et al. 39 citations

Abstract There has been a marked increase in the availability of synthetic drugs designed to mimic the effects of marijuana. These cannabimimetic drugs, sold illicitly as ‘Spice’ and related products, are associated with serious medical complications in some users. In vitro studies suggest that synthetic cannabinoids in these preparations are potent agonists at central cannabinoid CB1 receptors...

DOI: 10.1111/adb.12334 (opens in new tab) Synthetic cannabinoids Am251 Cannabinoid receptor Long-term potentiation +6

Cannabis-induced psychosis or Cannabis-associated psychosis: Diagnostically no clear winner

Journal of Mental Health and Human Behaviour 2016 Siddharth Sarkar, Srinivas Rajkumar, Yatan Pal Singh Balhara

Cannabis is the most commonly used illicit drug worldwide including India. The role of Cannabis in the causation of psychiatric disorders, especially psychosis remains debatable. Cannabis use has been reported to present with symptoms similar to those of schizophrenia and bipolar affective disorder. The distinction between Cannabis-induced psychoses and primary psychotic disorder is important...

Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.

British Journal of Pharmacology January 2016 S M Todd, Jonathon C Arnold

It has been proposed that medicinal strains of cannabis and therapeutic preparations would be safer with a more balanced concentration ratio of Δ(9) -tetrahydrocannabinol (THC) to cannabidiol (CBD), as CBD reduces the adverse psychotropic effects of THC. However, our understanding of CBD and THC interactions is limited and the brain circuitry mediating interactions between CBD and THC are...

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study

BMJ Open 2016 R. Patel, R. Wilson, R. Jackson et al.

Objective To investigate whether cannabis use is associated with increased risk of relapse, as indexed by number of hospital admissions, and whether antipsychotic treatment failure, as indexed by number of unique antipsychotics prescribed, may mediate this effect in a large data set of patients with first episode psychosis (FEP). Design Observational study with exploratory mediation analysis....

Cross-generational THC exposure alters the developmental sensitivity of ventral and dorsal striatal gene expression in male and female offspring.

Neurotoxicology and Teratology 2016 Henrietta Szutorisz, Gabor Egervari, James Sperry et al.

Cannabis (Cannabis sativa, Cannabis indica) is the illicit drug most frequently abused by young men and women. The growing use of the drug has raised attention not only on the impact of direct exposure on the developing brain and behavior later in life, but also on potential cross-generational consequences. Our previous work demonstrated that adolescent exposure to Δ9-tetrahydrocannabinol...

Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users.

Cannabis and Cannabinoid Research 2016 Carrie Cuttler, Laurie K Mischley, Michelle Sexton

Introduction: Despite known sex differences in the endocannabinoid system of animals, little attention has been paid to sex differences in human's cannabis use patterns and effects. The purpose of the present study was to examine sex differences in cannabis use patterns and effects in a large sample of recreational and medical cannabis users. Methods: A large sample (n=2374) of cannabis users...

DOI: 10.1089/can.2016.0010 (opens in new tab) Full text (opens in new tab) Cannabis acute effects Cannabis withdrawal Medical cannabis Sex differences